Using Intermittent Pneumatic Compression Therapy to Improve Quality of Life for Symptomatic Patients With Infrapopliteal Diffuse Peripheral Obstructive Disease

この論文にアクセスする

この論文をさがす

著者

    • CHANG Shih-Tai
    • Division of Cardiology, Chang Gung Memorial Hospital, Chiayi & Chia-Yi School, Chang Gung Institute of Technology
    • HSU Jen-Te
    • Division of Cardiology, Chang Gung Memorial Hospital, Chiayi & Chia-Yi School, Chang Gung Institute of Technology
    • CHU Chi-Ming
    • Section of Health Informatics, Institute of Public Health, National Defense Medical Center and University
    • PAN Kuo-Li
    • Division of Cardiology, Chang Gung Memorial Hospital, Chiayi & Chia-Yi School, Chang Gung Institute of Technology
    • JANG Shih-Jung
    • Division of Cardiology, Chang Gung Memorial Hospital, Chiayi & Chia-Yi School, Chang Gung Institute of Technology
    • LIN Pi-Chi
    • Division of Cardiology, Chang Gung Memorial Hospital, Chiayi & Chia-Yi School, Chang Gung Institute of Technology
    • HSU Hung-Chih
    • Division of Rehabilitation, Chang Gung Memorial Hospital, Chiayi & Chia-Yi School, Chang Gung Institute of Technology
    • HUANG Kuo-Chin
    • Division of Orthopedic Surgery, Chang Gung Memorial Hospital, Chiayi & Chia-Yi School, Chang Gung Institute of Technology

抄録

<b><i>Background:</i></b> Although the acute effect of intermittent pneumatic compression (IPC) therapy had been documented for patients with symptomatic peripheral arterial obstructive disease (PAOD), its efficacy in improving quality of life (QOL), especially for those with infrapopliteal diffuse lesions, remains unclear. <b><i>Methods and Results:</i></b> Thirty-one patients with infrapopliteal diffuse or multiple segmental lesions were enrolled in the study. Based on receipt of IPC therapy (3h daily for 3 months), patients were allocated to a study (n=23) or control (n=8) group. The 6-min walking test, transcutaneous oxygen tension (TcPO<sub>2</sub>), and QOL evaluated with the Short-Form 36 questionnaire were measured at the beginning and end of the study. In the QOL analysis, scores for physical functioning, physical and emotional role functioning, bodily pain, and general and mental health showed significant changes after IPC therapy. In the 6-min walking test, duration, and the initial and absolute claudication distances were significantly increased in the study group. The TcPO<sub>2</sub> also significantly increased in the distal end of the target limb after IPC therapy. <b><i>Conclusions:</i></b> Patients at high risk for amputation with infrapopliteal diffuse or multiple segmental lesions can improve their walking ability, TcPO<sub>2</sub> of the target limb and QOL after IPC therapy. (<i>Circ J</i> 2012; <b>76:</b> 971-976)<br>

収録刊行物

  • Circulation journal : official journal of the Japanese Circulation Society

    Circulation journal : official journal of the Japanese Circulation Society 76(4), 971-976, 2012-03-25

    一般社団法人 日本循環器学会

参考文献:  34件中 1-34件 を表示

各種コード

  • NII論文ID(NAID)
    10030131551
  • NII書誌ID(NCID)
    AA11591968
  • 本文言語コード
    ENG
  • 資料種別
    ART
  • ISSN
    13469843
  • データ提供元
    CJP書誌  J-STAGE 
ページトップへ